Comparison of Acarbose and Metformin on Albumin Excretion in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial

Increased urinary albumin excretion in diabetes not only signals nephropathy but also serves as a risk marker for cardiovascular disease. The data of MARCH (Metformin and AcaRbose in Chinese as the initial Hypoglycaemic treatment) trial demonstrated that acarbose and metformin were similarly efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Qingrong, Xu, Yuan, Yang, Ning, Gao, Xia, Liu, Jia, Yang, Wenying, Wang, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998782/
https://www.ncbi.nlm.nih.gov/pubmed/27057866
http://dx.doi.org/10.1097/MD.0000000000003247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998782/
https://www.ncbi.nlm.nih.gov/pubmed/27057866
http://dx.doi.org/10.1097/MD.0000000000003247

Ejemplares similares